Safety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy

被引：0

作者：

Shi, Y-K. ^{[1
]}

Zhang, S. ^{[2
]}

Hu, X. ^{[1
]}

Feng, J. ^{[3
,14
]}

Ma, Z. ^{[4
]}

Zhou, J. ^{[5
]}

Yang, N. ^{[6
]}

Wu, L. ^{[7
]}

Liao, W. ^{[8
]}

Han, X. ^{[9
]}

Wang, Z. ^{[10
]}

Zhang, X. ^{[11
]}

Qin, S. ^{[12
]}

Ying, K. ^{[13
]}

Feng, J. ^{[3
,14
]}

Fang, J. ^{[10
]}

Liu, L. ^{[15
]}

Jiang, Y. ^{[16
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China

[2] Capital Med Univ, Beijing Chest Hosp, Dept Oncol, Beijing, Peoples R China

[3] Jiangsu Canc Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China

[4] Henan Prov Canc Hosp, Dept Resp Med, Zhengzhou, Henan, Peoples R China

[5] Zhejiang Univ, Affiliated Hosp 1, Dept Resp Med, Coll Med, Hangzhou, Zhejiang, Peoples R China

[6] Hunan Canc Hosp, Dept Pulm Oncol, Changsha, Hunan, Peoples R China

[7] Hunan Canc Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China

[8] Nanfang Med Univ, Nanfang Hosp, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China

[9] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China

[10] Peking Univ, Dept Pulm Oncol, Canc Hosp, Beijing, Peoples R China

[11] Nantong Tumor Hosp, Dept Med Oncol, Nantong, Peoples R China

[12] Nanjing Univ Chinese Med, Med Oncol, PLA Canc Ctr, Bayi Hosp, Nanjing, Jiangsu, Peoples R China

[13] Zhejiang Univ, Sch Med, Dept Resp Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China

[14] Nantong Univ, Dept Resp Med, Affiliated Hosp, Nantong, Peoples R China

[15] Huazhong Univ Sci & Technol, Union Hosp, Dept Thorac Oncol, Tongji Med Coll,Canc Ctr, Wuhan, Peoples R China

[16] Shanghai Allist Pharmaceut Inc, Clin Affairs & Regulatory Dept, Shanghai, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1531P

引用

页码：629 / 629

页数：1

共 50 条

[41] The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
Pan, Guoqiang
Chen, Kaiyan
Yu, Xiaoqing
Sheng, Jiamin
Fan, Yun
TRANSLATIONAL CANCER RESEARCH, 2021, 10 (06) : 2895 - 2905
[42] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Shuhang Wang
Shundong Cang
Delong Liu
Journal of Hematology & Oncology, 9
[43] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Wang, Shuhang
Cang, Shundong
Liu, Delong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[44] Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC)
Jenkins, S.
Yang, J.
Ramalingam, S.
Yu, K.
Patel, S.
Weston, S.
Lawrance, R.
Cantarini, M.
Janne, P.
Mitsudomi, T.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S153 - S154
[45] Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer
Prim, Nathalie
Quoix, Elisabeth
Beau-Faller, Michele
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1615 - 1616
[46] Osimertinib in previously EGFR-TKI treated non-small cell lung cancer (NSCLC) patients without T790M mutation: Real-world evidence.
Luo, Yung-Hung
Liu, Han
Wampfler, Jason A.
Tazelaar, Henry D.
Li, Yalun
Peikert, Tobias
Liu, Dan
Leventakos, Konstantinos
Chen, Yuh-Min
Yang, Yanan
Chiou, Shih-Hwa
Yang, Ping
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[47] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
Shinno, Y.
Goto, Y.
Sato, J.
Morita, R.
Matsumoto, Y.
Murakami, S.
Kanda, S.
Horinouchi, H.
Fujiwara, Y.
Yamamoto, N.
Ohe, Y.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
[48] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Matsuo, Norikazu
Azuma, Koichi
Sakai, Kazuko
Hattori, Satoshi
Kawahara, Akihiko
Ishii, Hidenobu
Tokito, Takaaki
Kinoshita, Takashi
Yamada, Kazuhiko
Nishio, Kazuto
Hoshino, Tomoaki
SCIENTIFIC REPORTS, 2016, 6
[49] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Norikazu Matsuo
Koichi Azuma
Kazuko Sakai
Satoshi Hattori
Akihiko Kawahara
Hidenobu Ishii
Takaaki Tokito
Takashi Kinoshita
Kazuhiko Yamada
Kazuto Nishio
Tomoaki Hoshino
Scientific Reports, 6
[50] Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib
Tang, Kejing
Jiang, Neng
Kuang, Yukun
He, Qiong
Li, Shuhua
Luo, Jiping
Jiang, Wenting
Chen, Yangshan
Sun, Yu
Chen, Lili
Chen, Yanyang
Zhu, Junfeng
Cui, Yongmei
Wan, Han
Ke, Zunfu
THORACIC CANCER, 2019, 10 (02) : 359 - 364

← 1 2 3 4 5 →